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Abstract 
The aim of this study was to develop a formulation, containing the propolis standardized 
extract (EPP-AF
®), which can assist in the healing of skin lesions. To achieve this objective the 
antimicrobial activity and chemical composition of the propolis extract was determined. The 
final product was subjected to in vitro and in vivo pre-clinical evaluation. The broth macrodi-
lution method was used to determine the antimicrobial activity of the extracts and formula-
tions against the microorganisms most commonly found in burns, Pseudomonas aeruginosa, 
Klebsiella pneumoniae,  Escherichia coli,  Staphylococcus aureus and  Staphylococcus epidermidis. 
Wistar rats with puncture wounded skin were used to evaluate the wound healing properties 
of  propolis.  The  results  of  chemical  and  biological  characterization  demonstrated  the 
batch-to-batch reproducibility of the standardized extract which is an unprecedented result. 
The antimicrobial and wound healing activity of the pharmaceutical studied showed the best 
results  when  samples contain  3.6%  propolis,  suggesting  that  this  is  the most  promising 
composition. 
Key words: propolis, EPP-AF®, antimicrobial activity, wound healing, pharmaceutics, reproduci-
bility 
Introduction 
Thermal injury is a major cause of morbidity and 
impaired quality of life in many areas of the world. 
Each year in The United States of America, more than 
1.25 million people suffer burns. It has been estimated 
that 75% of deaths following burn injuries are related 
to infection [1]. 
The  optimal  dressing  for  the  outpatient  treat-
ment of partial-thickness thermal burns continues to 
challenge emergency physicians and surgeons. While 
the ideal dressing material should be of low cost, safe 
and relatively painless, it should also discourage in-
fection and promote fast wound healing to minimize 
morbidity and optimize functional and cosmetic out-
comes.  Furthermore,  to  increase  outpatient  compli-
ance,  the  number  of  dressing  changes  should  be 
minimized and be easily performed at home with the 
slightest amount of discomfort [2].  
Nalbandian et al. (1987) developed a poloxamer 
407  gel  for  dermatological  and  burn  treatment,  be-
cause of its water solubility, adherence and easy ap-
plication  and  removal  from  the  burn  sites  [3]. 
Poloxamer 407 is an inert, atoxic substance that is able 
Ivyspring  
International Publisher   Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
513 
to generate thermoreversible colloidal solutions in the 
presence of water, as a consequence of its aggregation 
into micelles, which occurs with increasing tempera-
ture, minimizing the free energy of the solution. At 
low temperatures, the polymer exists as a monomer in 
solution.  Upon  warming,  a  balance  is  established 
between monomers and micelles, and aggregates are 
formed [4].  
In  addition  to  the  need  for  more  convenient 
wound  dressing  and  pharmaceuticals,  it  is  also  im-
portant to discover therapeutic agents that are more 
effective  against  microbial  infections  frequently  re-
lated with burns.  
Propolis is a resinous balsamic material, with a 
complex chemical composition, which is collected by 
bees from sprouts, exudates of trees and other parts of 
the plants. It is modified in the beehive by addition of 
salivary secretions and wax [5]. It is used by bees for 
protection,  repair  of  holes  and  damage  to  the  hive, 
and  for  the  construction  of  aseptic  places  for  the 
queen to lay her eggs [6]. More than 150 components, 
including  polyphenols,  terpenoids,  steroids,  sugars 
and amino acids, have been identified in raw propolis. 
Its  chemical  composition  is  influenced  by  botanical 
and  geographical  factors,  as  well  as  the  collection 
season. In general, propolis consists of 50% resin and 
vegetable  balsam,  30%  wax,  10%  essential  and  aro-
matic  oils,  5%  pollen,  and  5%  other  substances  in-
cluding organic debris [7]. 
Several  studies  have  been  published  on  the 
many different existing  propolis extracts, both with 
regard to their biological activities [8-10] and safety 
[7]. However, it is impossible to compile all data for 
the  generation  of  a  pharmaceutical  product.  The 
origin, composition and extractive processes alter the 
extract obtained and subsequently biological behavior 
of the product. Therefore, the propolis standardized 
extract (EPP-AF®) used in this study offers some ad-
vantages over the others, since some of its biological 
activities [5; 11-14] and safety [11] have been studied 
previously  in  other  models,  which  allowed  greater 
security for the realization of this proposal. 
The  EPP-AF®  showed  anti-inflammatory  [11], 
anti-ulcer [12], antimicrobial [13], antioxidant [5] and 
antifungal activities [14]. Furthermore, its safety has 
been demonstrated [11] and the absence of cytotoxi-
city and mutagenic potential evaluated [15-16]. With 
the data available, all obtained from the same extract 
with the same composition of the propolis raw mate-
rial, and the same chemical extracting process,  it is 
possible to get a drug. Aiming to achieve this goal, 
this  study  proposed  to  evaluate  three  batches  of 
EPP-AF® assessing its chemical composition and bio-
logical  properties  in  order  to  determine  the  repro-
ducibility of the product batch-to-batch. 
For  wound  dressing  application,  several  poly-
meric materials have been investigated with success-
ful outcomes, but an ideal skin substitute with struc-
tural  and  functional  properties  similar  to  those  of 
human skin requires further investigated [17].  
Considering this information, a pharmaceutical 
compound  was  developed,  containing  the  propolis 
extract, designed to be used for treating wounds, as a 
product suited for this application is still required. In 
addition to the chemical characterization of the prop-
olis extracts and evaluation of its reproducibility, the 
final product was subjected to in vitro (antimicrobial 
activity)  and  in  vivo  (wound  healing)  pre-clinical 
evaluation.  
Materials and Methods 
Chemicals 
Three  batches  of  green  propolis  standardized 
extracts  (EPP-AF®):  A  (010/08),  B  (1440110)  and  C 
(1400410),  were  kindly  provided  by  Apis  Flora  Co. 
(Ribeirão  Preto,  São  Paulo,  Brazil)  (patent  PI 
0405483-0, Revista de Propriedade Industrial No. 1778 
of  01/02/2005).  Propolis  glycolic  extract  (PGE)  was 
obtained from EPP-AF® after evaporation of the eth-
anol portion and the addition of propyleneglycol to 
achieve  30%  w/v  of  dry  matter.  For  quantitative 
analysis caffeic, p-coumaric and trans-cinnamic acids 
(Sigma-Aldrich , São Paulo, Brazil); artepillin C (Wako 
Pure  Chemical  Industries  Co.,  Osaka,  Japan);  gallic 
acid  (Labsynth,  Diadema,  Brazil);  isosakuranetin 
(ChromaDex,  Irvine,  Canada)  and  aromaden-
drin-4´-O-methyl ether (previously isolated and iden-
tified as described by Sousa et al. [18] and kindly do-
nated  by  the  authors)  were  used.  Methanol 
HPLC-grade was obtained from J.T. Baker and water 
was treated in a Milli-Q water purification system. All 
other chemicals were of reagent grade and were used 
without further purification. Mueller Hinton agar and 
Mueller Hinton broth (Difco, Detroid, MI, USA), were 
used for the microbial assays. 
Chemical Analysis of propolis extracts by 
HPLC  
The  propolis  extracts  were  analyzed  by  HPLC 
using  a  Shimadzu  apparatus  equipped  with  a 
CBM-20A controller, a LC-20AT quaternary pump, a 
SPD-M 20A diode-array detector, and Shimadzu LC 
solution  software,  version  1.21  SP1.  A  Shimadzu 
Shim-Pack CLC-ODS column (4.6 mm x 250 mm, par-
ticle diameter of 5 µm, pore diameter of 100 Å) was 
used. The mobile phase consisted of methanol (B), and Int. J. Biol. Sci. 2012, 8 
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of a solution of water-formic acid (0.1% v/v), pH 2.7 
(A).  The  method  consisted  of  a  linear  gradient  of 
20-95% of B over a period of 77 minutes at a flow rate 
of 0.8 ml/min. Detection was set at 275 nm. 
Propolis  extracts  were  diluted  with  5  ml  of 
methanol (HPLC grade) in 10 ml volumetric flasks, 
subjected  to  sonication  for  10  minutes  and  filled  to 
volume with Milli-Q water. The samples were filtered 
through a 0.45 µm filter before analysis. 
Preparation of thermoreversible formulations 
The raw material used for the formulations in-
cluded  the  polymer  poloxamer  407,  a  co-surfactant 
ethoxylated  castor  oil  (BASF,  São  Paulo,  Brazil)  so-
dium sorbate (Labsynth, Diadema, Brazil) and water. 
The  gels  (patent  PI  0806114-9)  were  prepared  on  a 
weight  basis  using  the  cold  method  according  to 
Schmolka  [19].  Appropriate  amounts  of  PGE  and 
co-surfactant were mixed  to yield 1.2, 2.4 and 3.6% 
(w/w) dry propolis extract (samples 1, 2 and 3, re-
spectively),  in  accord  with  previous  publication  by 
our group [15]. Two control samples were prepared: 
one  consisting  of  the  polymer  dispersion  in  water 
(control 1) and the other of polymer and co-surfactant 
in water (control 2) at concentrations same to those 
used for the propolis gels.  
Antimicrobial activity 
Pseudomonas  aeruginosa  ATCC  27853,  Klebsiella 
pneumoniae ATCC 10031, Escherichia coli ATCC 25922, 
Staphylococcus aureus ATCC 25923, Staphylococcus au-
reus  ATCC  43300,  and  Staphylococcus  epidermidis 
ATCC 14990 were acquired from the American Type 
Culture Collection (ATCC). 
The three batches of EPP-AF® (A, B and C) and 
the formulations (samples 1, 2 and 3) containing the 
PGE extracts respectively, and the controls (1 and 2) 
were evaluated.  
The  antimicrobial  activity  of  the  EPP-AF®  and 
formulations were determined by the broth macrodi-
lution method [20] with some adaptations for natural 
products. Sterile test tubes and Mueller Hinton broth 
were used for the tests. 
As a result of the turbidity that occurred in test 
broth when EPP-AF® was diluted, it was not possible 
to determine the minimum inhibitory concentration 
(MIC).  Therefore,  the  antimicrobial  activity  of  the 
EPP-AF®  was  assessed  by  means  of  the  minimum 
bactericidal  concentration  (MBC),  which  was  deter-
mined by subculturing 20 l aliquots from each tube 
in the broth dilution series onto Mueller Hinton agar 
plates. The plates were incubated at 35°C for 24 h. The 
MBC was defined as the lowest concentration of the 
sample  required  to  kill  the  microorganism  being 
tested. In the case of the gels, this turbidity does not 
occur  and  therefore  the  antimicrobial  activity  was 
determined by MIC [20]. 
In vivo models for wound healing activity 
Thirty  male  Wistar  rats  (Rattus  norvegicus, 
Berkenout, 1769) with an initial body weight of 45 g, 
obtained from the Central Animal House, Faculty of 
Medicine of Ribeirão Preto, University of São Paulo, 
Brazil, were used. The protocol was approved by the 
Ethics Committee for Animal Care of the University 
of Franca (process 121/05). 
A lesion was created with a punch on the back of 
animals  previously  anesthetized  by  intraperitoneal 
administration of ketamine, midazolam and acepram 
[21]. After surgery the animals received no additional 
treatment  (antibiotics  or  anti-inflammatory  drugs), 
only  food  and  water  ad  libitum.  The  cages  were 
cleaned  daily  and  kept  in  air  conditioned  environ-
ment.  The  concentrations  of  the  propolis  extract 
added to the formulations used in the present study 
were established based on ethnopharmacological in-
formation [22]. The animals were treated with gels in 
the presence and absence of propolis (EPP-AF®) (n = 
3). The animals were fed and weighed daily. 
The healing process was evaluated by two ex-
perimental protocols. At first, there was a single ap-
plication of the product under test, and the animals 
were sacrificed three days after the completion of the 
surgical incision (n = 3). In the second protocol, the 
products were applied twice a day (each 12 hours), 
and the animals were sacrificed three days after inci-
sion (n = 3). 
The animals were sacrificed with lethal doses of 
anesthetic and the tissue containing the lesions were 
fixed  in  4%  formaldehyde  in  Sorensen  phosphate 
buffer  0.1  M,  pH  7.3.  The  samples  were  placed  in 
paraffin and sliced by a microtome in slices of 6 µm. 
The  sections  were  stained  with  Masson  trichrome 
staining and analyzed by optical microscopy [23]. 
The  micro  measurements  of  the  affected  area 
were performed using three sections per rat with 25 
µm of distance between each section totaling 93 µm 
per treatment. The morphometry of the lesion, in all 
groups and treatments, was evaluated using an image 
analyzer  KS300  -  Zeiss  (Axion  Vision)  with  a  40x 
magnification. The results are presented as mean tis-
sue filler by micrometers. 
Statistical analysis 
The  statistical  analysis  was  performed  by  the 
Pearson  correlation  coefficient  (r)  obtained  by  the 
correlation  of  the  markers  in  three  batches  studied 
(n=4).  The  r2 value  was  expressed  as  percentage  of Int. J. Biol. Sci. 2012, 8 
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correlation. The Pearson´s coefficients obtained were 
subjected  to  analysis  of  variance  (ANOVA)  with 
Bonferroni multiple comparison post-test (level of sig-
nificance of 5%). The data of the antimicrobial activity 
were submitted to the nonparametric Kruskal-Wallis 
test  (significance  level  of  1%).  Statistical  analysis  of 
data  was  performed  using  the  software  Graph  Pad 
Prism 4. 
Results 
Chemical characterization of EPP-AF® 
Correlation analyses indicated that there was a 
significant  relationship  between  batch  A  and  B 
(99.61%),  B  and  C  (99.72%),  and  between  A  and  C 
(99.71%), demonstrating the chemical reproducibility 
of the three batches (p>0.05). The chemical character-
ization  results  demonstrate  that  the  three  batches 
studied were similar, since the presence and quanti-
fication  of  the  six  standards  studied  (caffeic, 
p-coumaric and trans-cinnamic acids, aromadendrin, 
isosakuranetin  and  artepillin  C)  were  similar 
batch-to-batch (p>0.05).  
Table  1  and  Figure  1  show  the  quantitative 
analysis  of  the  three  batches  of  EPP-AF®  and  their 
chromatograms, respectively. 
 It  is  important  to  point  out  that  the  chemical 
markers quantified represent three important groups 
of metabolites commonly found in propolis products: 
the  flavonoids,  the  prenilated  phenolic  compounds 
and  phenolic  acids.  The  unidentified  peaks  in  the 
chromatograms are undergoing further investigation. 
Nonetheless, the chemical markers used in this study 
are  distributed  along  the  chromatogram  allowing 
more confidence for chemical profile analysis. 
 
 
 
Table 1 Chemical characterization of the standardized 
propolis extracts (EPP-AF
®) used in this study (n=4) (mg/g). 
Compounds  Standardized Propolis Extract 
Aa  Bb  Cc 
caffeic acid  0.299  0.024  0.336  0.027  0.288  0.009 
p- coumaric acid  1.561  0.090  1.524  0.108  1.486  0.052 
trans-cinnamic acid  0.091  0.055  0.167  0.001  0.153  0.009 
aromadendrin  1.020  0.168  0.993  0.075  1.125  0.022 
isosakuranetin  2.261  0.135  2.256  0.144  2.265  0.084 
artepilin C  7.553  1.497  8.533  0.522  6.962  0.261 
a Batch 010/08 of EPP-AF®.  
b Batch 1440110 of EPP-AF®.  
c Batch 1400410 of EPP-AF®. 
 
 
 
Figure 1: Chromatographic profile of (a) Propolis Standardized 
Extract (EPP-AF®) Batch 1440110 ; (b) Batch 1400410 and (c) 
Batch 010/08. Chromatographic profile includes the compounds: 
1. Caffeic acid (around 15 min.); 2. p-coumaric acid (around 20 
min.); 3. trans-cinnamic acid (around 36 min.), 4. aromadendrin (38 
min.) 5. isosakuretin (around 48 min.) and 6.Artepillin C (around 
61 min.). The chromatograms were plotted at 275 nm, using the 
RP-HPLC, C18 (Shim-pack, CLC-ODS (M), 25 cm x 4.6) column 
and gradient elution with methanol and acidic water (formic acid 
pH=2.7). 
 
Antimicrobial activity of EPP-AF® Extracts – 
Minimal Bactericidal Concentration (MBC) 
The three batches of EPP-AF® studied, showed in 
vitro antimicrobial activity against all the tested mi-
croorganisms  (Table  2).  The  statistical  analysis 
demonstrated  no  significant  difference  (p0.05) 
among the three batches (A, B and C). Gram positive 
bacteria  (Staphylococci)  were  more  sensitive  to 
EPP-AF® than Gram negative bacteria (P. aeruginosa, 
K. pneumoniae and E. coli) (p<0.01).  Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
516 
Table 2: Minimum bactericidal concentration (MBC) of the 
three batches of standardized propolis extract (EPP-AF
® - 
A, B and C) (n=3). 
Microorganism    MBC 
(mg/mL) 
 
Aa 
Mean 
(SD) 
Bb 
Mean (SD) 
Cc 
Mean 
(SD) 
Pseudomonas aeruginosa 
ATCC 27853 
14.05 
(0.00) 
13.93 (0.00)  14.00 
(0.00) 
Klebsiella pneumoniae ATCC 
10031 
14.05 
(0.00) 
13.93 (0.00)  14.00 
(0.00) 
Escherichia coli ATCC 25922  14.05 
(0.00) 
13.93 (0.00)  14.00 
(0.00) 
Staphylococcus aureus ATCC 
25923 
7.02 (0.00)  6.96 (0.00)  7.00 (0.00) 
Staphylococcus aureus ATCC 
43300 
3.51 (0.00)  3.48 (0.00)  3.50 (0.00) 
Staphylococcus epidermidis 
ATCC 14990 
7.02 (0.00)  6.96 (0.00)  7.00 (0.00) 
a Batch 10/08 of EPP-AF® (11.24% w/v dry propolis extract).  
b Batch 1440110 of EPP-AF® (11.15% w/v dry propolis extract). 
c Batch 1400410 of EPP-AF® (11.20% w/v dry propolis extract). 
 
 
Wound Healing activity 
The  histological  slices  obtained  from  animals 
treated with saline (control), gel without propolis and 
gel containing 1.2%, 2.4% and 3.6% w/v (dry matter) 
of propolis during the three days treatment. Figure 2A 
corresponds to the injured tissue treated with saline, 
while Figures 2 B and C depict the treatment with gel 
in  the  absence  of  propolis.  The  histological  section 
shows the onset of the healing process, where there is 
an  intense  presence  of  immune  cells,  especially  the 
cream leukocytes (arrows). 
Treatment  with  the  sample  1,  which  con-
tained1.2%  propolis  shows  the  healing  process  is 
more developed. In addition there is the presence of a 
large number of newly formed vessels, fibroblasts and 
the presence of plasma cells (Figure 3A and B). With 
this treatment it can be seen that epithelial cells are 
organizing clots just below the initial lesion (arrow - 
Figure  3A)  and  the  presence  of  collagen  fibers  was 
noted (Figure 3 B).  
Treatment  with  the  sample  2,  containing  2.4% 
propolis  demonstrated  earlier  healing  than  that  ob-
served with sample 1. Figure 4A shows the closure of 
the injury, where there is a region with epithelial cells 
and the presence of organized collagen fibers (arrow). 
Subcutaneously (Fig. 4B) it is clear the tissue contains 
fibroblasts and collagen, and also a large number of 
mitotic  cells  (arrows),  showing  that  propolis  stimu-
lates cell proliferation and tissue repair. 
 
 
 
Figure 2: Photograph showing the healing process of the control group (A) and the group treated with gel in the absence of propolis (B 
and C) after 3 days of treatment. Slices of 6 m were obtained and stained with Masson´s trichromic. a) Lesions treated with saline 
(control). Start of the healing process (100x magnification); b) Lesions treated with gel without propolis. Start of the healing process (100x 
magnification); c) Lesions treated with gel without propolis. Cream leukocitary cells (arrow) observed just below the initial clot (*) (400X 
magnification). 
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Figure  3: Photograph showing the healing process after three 
days of treatment with the gel containing 1.2% of dry extract of 
propolis.  a)  Lesions  treated  with  gel  containing  standardized 
extract of propolis (1.2%) in the subcutaneous tissue. The reor-
ganization of epithelial cells (c) and increased collagen fibers were 
observed just below the initial clot (*). Slices of 6 m were ob-
tained and stained with Masson´s trichromic (100x magnification); 
b)  lesions  treated  with  gel  containing  standardized  extract  of 
propolis (1.2%). There are a large number of fibroblasts synthe-
sizing collagen (arrow). Slices of 6 m were obtained and stained 
with Masson´s trichromic (400X magnification). 
 
Figure  4C  corresponds  to  the  treatment  per-
formed with sample 3, which contained 3.6% propo-
lis, where it is possible to see the tissue is completely 
reconstituted, where all the corneal layer is formed, 
consisting of properly organized epithelial tissue (1). 
The  subcutaneous  region  presents  a  dense  and 
well-structured tissue with the presence of collagen, 
however without the required extracellular matrix.  
Histological findings have shown that with just 
one  application  of  the  gels  containing  EPP-AF®,  an 
organized  tissue  was  formed  and  maintained  with 
physiological  functions  (Figure  4).  It  could  also  be 
observed that the healing effect was almost the same 
between  the  concentrations  of  2.4%  and  3.6%.  The 
repetition of the applications was more effective when 
we compare the morphometric analysis of the healing 
area. The analysis noted that the area of newly formed 
tissue was significantly higher for the individual ap-
plications  of  samples  2  and  3  when  compared  to 
sample  1  application.  No  significant  difference  in 
morphometric area was observed between samples 2 
and 3 (p>0.05). 
 
 
Figure  4: Photograph showing the healing process after three 
days of treatment with the gels containing either 2.4% or 3.6% 
propolis. Slices of 6 m were obtained and stained with Masson´s 
trichromic. a) Lesions treated with the 2.4% propolis gel. Closing 
of the lesion in the epithelial layer (1) and subcutaneously (2) there 
is a large number of fibroblasts synthesizing collagen (arrow) (100x 
magnification);  b)  Lesion  treated  with  the  2.4%  propolis  gel. 
Subcutaneously (2) there is an increase of collagen fibers and a 
large number of cells undergoing mitosis (arrow) (400X magnifi-
cation); c) Lesions treated with the 3.6% propolis gel. Wound area 
completely  rebuilt,  the  epithelium  (1)  is  already  presented  in 
several  layers  forming  the  corneal  region.  Subcutaneously  (2) 
thicker collagen fibers (arrow) were observed (400X magnifica-
tion). 
 Int. J. Biol. Sci. 2012, 8 
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Through  the  data  presented  with  increasing 
concentration of propolis, a greater number of mitotic 
cells were observed, suggesting a role for this product 
as a stimulator of fibroblast growth. The present re-
sults showed the healing activity of the gel containing 
EPP-AF®, especially with samples 2 and 3, after three 
days of treatment, while in the control group, seven 
days was required to obtain tissue repaired. 
Antimicrobial activity of Thermoreversible 
Gels – Minimal Inhibitory Concentration (MIC) 
Samples 1 and 2 were not effective against the 
tested microorganisms (Table 3). However, sample 3 
showed in vitro antimicrobial activity against all mi-
croorganisms  (Table  3).  Sample  3  was  statistically 
more efficacious in inhibiting growth of the microor-
ganisms than samples 1 and 2 (p0.001). No signifi-
cant difference was found between samples 1 and 2 
(p0.05). Control sample (without EPP-AF®) was not 
effective against the tested microorganisms. 
Discussion 
Sforcin  and  Bankova  (2011)  [24]  presented  the 
difficulties in developing a drug based on propolis, 
although  numerous  scientific  data-sets  have  shown 
the biological activities of propolis and its safety. The 
origin of propolis, its mode of production and chem-
ical composition can be different, hindering obtaining 
a safe and effective medicine. 
Batch variability is a common drawback in the 
manufacture of plant extracts. Medicinal use of natu-
ral  compounds  must  rely  on  appropriate  quality, 
safety,  and  efficacy  requisites.  In  this  regard, 
batch-to-batch  reproducibility  is  essential  to  ensure 
consistent quality. In the present study, compounds 
such  as  phenolics,  cinnamic  acid  derivatives,  flavo-
noids  (aromadendrin  and  isosakuranetin),  a  repre-
sentative of prenylated p-coumaric acids, artepillin C, 
an  important  and  internationally  recognized  bi-
omarker for propolis of the Brazilian type [15;18].  
The  results  presented  in  this  study,  demon-
strated for the first time in the literature the chemical 
reproducibility of three independent batches of prop-
olis extract compared with six standards. Almeida et 
al. (2010) studied the chemical and functional repro-
ducibility  of  the  extracts  from  Castanea  sativa,  by 
comparing the fingerprint of the three extracts with 
respect  of  the  phenolic  composition.  Although  the 
chromatographic profile showed several peaks, like in 
this  study,  only  the  hyperoside,  isoquercitrin,  rutin 
and ellagic acid were identified [25]. The identifica-
tion and analysis of some applicable chemical markers 
(not all peaks found in the chromatogram) is common 
in phytotherapeutic studies because it is quite difficult 
to identify all compounds in the sample. Nonetheless, 
the  batch-to-batch  reproducibility  can  be  demon-
strated considering a group of standards. Then, in the 
presented investigation, although all the peaks pre-
sented  in  the  chromatograms  were  not  identified 
(studies  running),  the  chemical  reproducibility  ob-
tained  is  a  remarkable  fact  considering  the  area  of 
research in question. Working in the field of techno-
logical innovation, these findings suggest that propo-
lis EPP-AF® can be used as a drug. 
 
Table 3 Minimum inhibitory concentration (MIC) of the formulations (samples 1, 2 and 3) containing the batches A, B and 
C of standardized propolis extract (EPP-AF
®) (n=3). 
Microorganism  MIC (mg/mL) 
Sample 1a  Sample 2b  Sample 3c 
Ad 
Mean (SD) 
Be 
Mean (SD) 
Cf 
Mean (SD) 
A 
Mean (SD) 
B 
Mean (SD) 
C 
Mean (SD) 
A 
Mean (SD) 
B 
Mean (SD) 
C 
Mean (SD) 
P. aeruginosa ATCC 27853   6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
18 
(0.00) 
18 
(0.00) 
18 
(0.00) 
K. pneumoniae 
ATCC 10031 
 6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
18 
(0.00) 
18 
(0.00) 
18 
(0.00) 
E. coli 
ATCC 25922 
 6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
18 
(0.00) 
18 
(0.00) 
18 
(0.00) 
S. aureus  
ATCC 25923 
 6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
9 
(0.00) 
9 
(0.00) 
9 
(0.00) 
S. aureus  
 ATCC 43300 
 6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
9 
(0.00) 
9 
(0.00) 
9 
(0.00) 
S. epidermidis ATCC 14990   6 
(0.00) 
 6 
(0.00) 
 6 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
 12 
(0.00) 
9 
(0.00) 
9 
(0.00) 
9 
(0.00) 
a 1.2% (w/v) propolis dry extract; b 2.4% (w/v) propolis dry extract; c 3.6% (w/v) propolis dry extract; d Batch 010/08 of EPP-AF®; e Batch 
1440110 of EPP-AF®; f Batch 1400410 of EPP-AF®. 
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The  microorganisms  studied  P.  aeruginosa,  K. 
pneumoniae, E. coli, S. aureus and S. epidermidis. P. ae-
ruginosa are the most frequently isolated from injuries 
and burn wound, followed by K. pneumoniae, E. coli, S. 
aureus and the coagulase-negative staphylococci [1]. S. 
aureus ATCC 43300 is a methicillin-resistant S. aureus 
(MRSA). These strains are resistant to all penicillins, 
cephalosporins and carbapenems. However, EPP-AF® 
showed antimicrobial activity against these microor-
ganisms, demonstrating the functional reproducibility 
of EPP-AF® similar to that obtained by Almeida et al. 
(2010) in the case of antioxidant activity of Castanea 
sativa  [25].  Furthermore,  EPP-AF®  killed  S.  aureus 
ATCC 43300 with a range of concentration 3.48 – 3.51 
mg/ml, while it killed other staphylococci with higher 
concentrations  (6.96  -  7.02  mg/ml)  (Table  2). 
Gram-negative bacteria were killed with higher con-
centrations  of  EPP-AF®.  Erkmen  and  Özcan  (2008) 
[26] reported that Gram-positive bacteria were more 
susceptible  to  Turkish  propolis  extracts  than 
Gram-negative bacteria. Similar result occurred with 
the propolis evaluated in this work.  
Until  the  present  moment,  the  mechanisms  of 
action related to the biological activities of propolis 
remains  unknown.  Menna-Barreto  et  al.  (2009) 
showed  that  susceptibility  of  T.  cruzi  treated  with 
propolis was affected by the reservosomes, suggesting 
a failure in the lipid metabolism, affecting membrane 
fluidity  and  leading  to  cell  lysis  [27].  Takaisi  & 
Schilcher (1994) suggested that the antimicrobial ac-
tivity of propolis is due to a combined action of pi-
nocembrine, galangin and caffeic acid phenethyl ester 
(CAPE),  whose  action  is  based  on  the  inhibition  of 
bacterial RNA polymerase [28]. However, the flavo-
noid compounds presented in this works are charac-
teristic  of  propolis  originating  from  Poplar  buttons 
(Populus  sp.)  and  therefore  referring  of  European 
propolis, hence such data cannot simply be extrapo-
lated to the Brazilian propolis [24]. Furthermore, the 
research of CAPE in the EPP-AF® demonstrated that 
this compound is not present in its composition (data 
not shown). 
Recently, studies done by our group using Sac-
charomyces cerevisiae models demonstrated that short 
exposure  to  the  propolis  standardized  extract 
(EPP-AF®) was able to induce cell death by apoptosis, 
while contact for longer periods caused necrosis [14]. 
The results of De Castro et al. (2011) also indicate that 
cytochrome c and endonuclease G (Nuc 1p) are in-
volved in cell death induced by propolis and that the 
metacaspase YCA1 gene is one of the important me-
diators  in  this  induction.  Systems  biology  revealed 
enrichment for genes involved in the mitochondrial 
electron transport chain, vacuolar acidification, nega-
tive regulation of transcription from the RNA poly-
merase  II  promoter,  regulation  of  macroautophagy 
associated  with  protein  targeting  to  vacuoles,  and 
cellular  responses  to  starvation.  Validation  studies 
indicated that propolis sensitivity is dependent on the 
mitochondrial function and that vacuolar acidification 
and autophagy are important for cell death caused by 
propolis [14]. The same research group evaluated the 
six  standards  chosen  to  the  standardization  of  the 
EPP-AF®, individually and combined, in Saccharomy-
ces cerevisiae models, however no positive results were 
obtained with the standards when applied individu-
ally (1, 2, 5, 10, 25, 50, 100 and 200 µg/ml) or com-
bined (100 µg/ml each one) similar to the observation 
made by Urushisaki et al. (2011) using an antiinflu-
enza model [29].  
After  the  chemical  and  biological  characteriza-
tion of EPP-AF®, the next step was to develop an in-
terestingly  pharmaceutical  preparation,  with  a  dif-
ferent  and  advantageous  presentation  to  encourage 
patient  compliance  throughout  the  course  of  the 
treatment.  For  that,  a  polymeric  system  based  on 
poloxamer 407 gel was proposed, due to the thermo 
reversible  behavior  and  the  stable  arrangement  of 
micelles that offered a stable and beautiful prepara-
tion. Also, the safety of this gel has previously been 
evaluated in in vitro and in vivo models [15]. 
Inflammation can be divided into acute, chronic 
and  inflammation  related  to  immunity.  Any  factor 
that induces the tissue damage could be described as 
the  pathogenesis  of  inflammation.  There  are  two 
types of factors that induce inflammation: inflamma-
tory  stimulating  factor  including  physical  stimuli, 
such as burns and surgery, or chemicals such as acids, 
alkalis,  allergens;  and  biochemical  (microorganisms, 
parasites, endotoxins, toxins). Another route of stim-
ulating inflammation includes histamine, bradykinin, 
prostaglandins,  platelet  activating  factor  and 
pro-inflammatory  stimulation  factors  (TNF-α,  IL-1, 
IL-6,  cellular  chemotaxis  factor,  etc.),  among  others 
[30].  
The wound healing process occurs through a se-
ries of events coordinated and mediated by cytokines 
that require action in concert of many cell types. The 
first phase of the healing process is governed primar-
ily  by  various  inflammatory  cells  that  accumulate 
within  the  wound.  Platelets  are  among  the  first  in-
flammatory  mediators  to  arrive  at  the  injury  site, 
while neutrophils and macrophages arrive during the 
first two days after the injury occurred and typically 
precede  the  influx  of  fibroblasts,  lymphocytes  and 
endothelial  cells.  The  well-orchestrated  series  of 
events within which these cell types interact includes 
the release of cytokines, growth factor and other bio-Int. J. Biol. Sci. 2012, 8 
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active molecules, such as free radicals [31] that when 
successful culminate in the functional restoration of 
tissue integrity. 
In the present study, some samples of poloxamer 
gels  were prepared with  different concentrations  of 
the propolis dry extract,  since one of  the  objectives 
was to determine the best concentration of the propo-
lis extract to promote wound healing and to kill or 
suppress the growth of microorganisms presented in 
burnt patients wounds.  
The  results  demonstrated  that  the  presence  of 
propolis offered different results when compared to 
control (saline) and the poloxamer gel (without prop-
olis), suggesting that samples 2 and 3 demonstrated 
better results. It is important to mention that the ma-
trix formed is appropriate to the final objective, since 
larger quantities, than is required for the formation of 
reepithelization,  can  cause  hypertrophic  scars  and 
keloids, due to the excessive deposition of extracellu-
lar  matrix,  mainly  collagen,  as  well  as  other  sub-
stances,  such  as  glycoproteins,  glycosaminoglycans 
and proteoglycans [32]. When antimicrobial activities 
of the gels were analyzed, samples 1 and 2 demon-
strated  absence  of  antibacterial  activity  against  the 
bacterial  strains  tested.  These  samples  contained 
lower concentrations of dry propolis extract (1.2 and 
2.4%, respectively). Sample 3 (3.6% propolis), howev-
er, was effective against all microorganisms, suggest-
ing  this  thermoreversible  gel  is  the  best  option  to 
achieve the objective of this work. 
In  the  present  model  of  study,  epithelization 
concluded seven days after the injury. By this time, 
the structure of the subcutaneous tissue and collagen 
fibers, which provide support to the tissue, are com-
pletely reconstituted and a reorganization of the epi-
thelial  layer  is  observed,  a  process  that  culminates 
with  the  closing  of  the  injury.  In  the  treatments 
showed,  histological  sections  were  performed  three 
days  after  the  injury,  showing  the  relevance  of  the 
results obtained.  
The  anti-inflammatory  effect  of  propolis  has 
been attributed to various mechanisms such as inhib-
iting the production of eicosanoids and nitric oxide, 
antioxidant action, modulation of calcium ion mobi-
lization, angiogenesis and anti-leukocyte activity [33]. 
In  the  results  presented  here,  it  was  observed  that, 
when treated with the propolis gel, histological sec-
tions showed a decrease of leukocytes, the presence of 
new  blood  vessels  (angiogenesis)  and  fibroblasts, 
corroborating to the mechanisms previous related. 
The  increased  healing  activity  has  been  at-
tributed to increased collagen formation and angio-
genesis. Antioxidants have been shown to play a sig-
nificant  role  in  the  healing  and  anti-inflammatory 
process [34]. This information has also been demon-
strated  in  studies  with  asiaticoside,  obtained  from 
Centella asiatica, which also has an important healing 
action and demonstrated the increase of antioxidants 
in the new tissue formed after application of the ac-
tive. This data suggested that the increase in antioxi-
dant damaged areas can be an important factor in the 
healing process [31]. 
Numerous  substances  have  been  identified  in 
propolis  [35].  Its  pharmacological  properties,  espe-
cially  those  related  to  antimicrobial,  an-
ti-inflammatory and wound healing properties, were 
mainly attributed to the presence of flavonoids and 
phenolic compounds [8]. It is scientifically proven that 
flavonoids  reduce  lipid  peroxidation  not  only  by 
preventing or delaying the onset of cellular necrosis, 
but also by increasing vascularization. It is believed 
that  any  drug  that  inhibits  lipid  peroxidation  in-
creases the feasibility of collagen fibers by increasing 
resistance  and  circulation,  preventing  cell  damage 
and promotion of cell synthesis [36]. Furthermore, the 
flavonoids  and  terpenoids  are  also  responsible  for 
promoting the healing process of injuries, mainly due 
to  their  astringent  and  antimicrobial  characteristics 
that appear to be responsible for the contraction of the 
lesion and the increased rate of epithelialization [36]. 
Also,  flavonoids  exhibit  inhibitory  activity  of  cy-
clooxygenase (COX) and lipooxigenase, reduction of 
prostaglandin  E2  (PGE2)  and  expression  of  the  in-
ducible isoform of COX (COX-2).  
Conclusion 
In conclusion, the results of the chemical and bi-
ological  characterization  demonstrated  the 
batch-to-batch  reproducibility  of  the  EPP-AF®,  con-
sidering the standards and microorganisms studied. 
Furthermore, this extract was effective against all mi-
croorganisms tested. The results suggest that a new 
thermoreversible  pharmaceutical  form  containing 
propolis as active ingredient can offer an alternative 
therapeutics to treat skin injuries, since this prepara-
tion was effective against all microorganisms tested 
and  demonstrated  favorable  result  on  the  wound 
healing model used. 
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